A study assessing human genetics CETP gain-of-function cohorts and humanized mouse models found that inhibition of CETP may improve sepsis outcomes by maintaining HDL levels thereby modulating immunity (Trinder et al., 2021). The gene discussed is CETP; the disease is Sepsis.